NCT03810066 2024-05-09Exploring the Theragnostic Value of Osimertinib in EGFR-mutated Lung Cancer (THEROS)University Hospital, EssenPhase 2 Completed16 enrolled
NCT03394118 2021-04-27TAGRISSO (Osimertinib) in NSCLC Patients in Whom T790 Mutations Are Detected by Liquid BiopsyAsan Medical CenterPhase 2 Completed63 enrolled